Induction of IL-12 Secretion and Enhanced Surface Expression of B7.1/B7.2 and ICAM-1 in Human Monocytes Activated by the Vaccine Carrier Brucella Abortus: Correlation with in Vivo Generation of Cellular Immune Responses

  • H. Golding
  • M. B. Zaitseva
  • C. K. Lapham
  • B. Golding
Part of the NATO ASI Series book series (NSSA, volume 293)


It is well established that two cytokines, IFN-γ and IL-4, play an important role in the differentiation of Th0/Tc0 cells into effector types Th1/Tc1 or Th2/Tc2 cells during the initial phase of the immune response (O’Garra and Murphy, 1994). In addition to these lymphokines, it has been demonstrated that another cytokine, IL-12, is a pivotal positive factor in the differentiation of the Th1/Tc1 cell subset (Manetti et al, 1993). IL-12 is a heterodimeric protein consisting of p40 and p35 subunits (Kobayashi et al, 1989; Stern et al, 1990) that binds to its receptor of approximately 110 kDa (Chizzonite et al, 1992). The biologic activities of IL-12 include stimulatory effects on human NK cells and cytotoxic T cells (Bloom and Horvath, 1994; Chouaib et al, 1994; Kobayashi et al, 1989; Wolf et al, 1991), and induction of proliferation of activated, but not resting, CD4+ and CD8+ T cells (Bertagnolli et al, 1992; Gately at al, 1991; Perussia et al, 1992). IL-12 potentiates production of IFN-γ by Th1 and Th0 clones (Manetti et al, 1994), and also by NK and CD8+ cells (Croft et al, 1994; D’Andrea et al, 1992). Studies in the murine system demonstrated an important role for IL-12 in the development of immune protection against infectious agents such as Candida (Romani et al, 1992), Leishmania major (Afonso et al, 1994), Listeria in SCID mice (Tripp et al, 1994) and Schistosomiasis (Wynn et al, 1995). IL-12 was also shown to play an important role in IFN-γ-dependent protection against malaria (Sedegah et al, 1994) and tuberculosis (Zhang et al, 1994) in humans. The ability of IL-12 to induce protective immunity against many infections suggests that this cytokine should be a key component of vaccines designed to elicit strong cell-mediated immunity.


Human Immunodeficiency Virus Type Human Monocyte Human Natural Killer Cell Brucella Abortus P81S Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Afonso, L., Scharton, T.M., Vieira, L.Q., Wysocka, M., Trinchieri, G. and Scott, P. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science. 263: 235.PubMedCrossRefGoogle Scholar
  2. Bennink, J. R., Yewdell, J.W., Smith, G.L., Moller, C. and Moss, B. 1984. Recombinant vaccina virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells. Nature. 1: 578.CrossRefGoogle Scholar
  3. Bertagnolli, M.M., Lin, B.Y., Young, D. and Hermann, S.H. 1992. IL-12 augments antigen-dependent proliferation of activated T lymphocytes. J. Immunol., 149: 3778.PubMedGoogle Scholar
  4. Bloom, E.T. and Horvath, J.A. 1994. Cellular and molecular mechanisms of the IL-12-induced increase in allospecific murine cytolytic T cell activity. Implications for the age-related decline in CTL. J. Immunol., 152: 4242.PubMedGoogle Scholar
  5. Chizzonite, R., Truitt, T., Desai, B.B., Nunes, P., Podlaski, F.J., Stern, A.S. and Gately, M.K. 1992. IL-12 receptor. I. Characterization of the receptor on phytohemagglutin-activated human lymphoblasts. J. Immunol., 148: 3117.PubMedGoogle Scholar
  6. Chouaib, S., Chehimi, J., Bani, L., Genetet, N., Tursz, T., Gay, F., Trinchieri, G. and Mami-Choaib, F. 1994. Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T lymphocyte precursors into allospecific cytotoxic effectors. Proc. Natl. Acad. Sci. USA, 91: 12659.PubMedCrossRefGoogle Scholar
  7. Croft, M., Carter, L., Swain, S.L. and Dutton, R.W. 1994. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profile. J. Exp. Med., 180: 1715.PubMedCrossRefGoogle Scholar
  8. Damle, N.K., Klussman, K., Linsley, P.S., Aruffo, A. and Ledbetter, J.A. 1992, Differential regulatory effects of intracellular adhesion molecule-1 on costimulation by the CD28 counter receptor B7. J.Immunol., 149: 2541.PubMedGoogle Scholar
  9. D’Andrea, A., Rengaraju, M., Valiante, N.M., Chehimi, J., Kubin, M., Aste-Amezaga, M., Chan, S.H., Kobayashi, M., Yong, D., Nickbarg, E., Chizzonite, R., Wolf, S.F. and Trinchieri, G. 1992. Production of natural killer stimulatory factor (NKSF/IL-12) by peripheral blood mononuclear cells. J.Exp. Med., 176: 1387.PubMedCrossRefGoogle Scholar
  10. D’Andrea, A., Aste-Amezaga, M, Valiante, N.M., Ma, X., Kubin, M. and Trinchieri, G. 1993. Interleukin 10 inhibits human lymphocyte IFN-γ production by suppressing natural killer stimulatory factor/ interleukin-12 synthesis in accessory cells. J. Exp. Med., 178: 1041.PubMedCrossRefGoogle Scholar
  11. Ehlers, S. and Smith, K.A. 1991. Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory. J. Exp. Med., 173: 25.PubMedCrossRefGoogle Scholar
  12. Finkelman, F.D., Katona, I.M., Mosmann, T.R. and Coffman, R.L. 1988, IFN-γ regulate the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol., 140: 1022.PubMedGoogle Scholar
  13. Gately, M.K., Desai, B.B., Wolitzky, A.G., Quinn, P.M., Dwyer, C.M., Podlaski, F.J., Familletti, P.C., Sinigaglia, F., Chizonnite, R., Gubler, U. and Stern, A.S. 1991. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic maturation factor). J. Immunol., 147: 874.PubMedGoogle Scholar
  14. Gimmi, C.D., Freeman, G.J., Gribben, J.G., Sugita, K., Freedman, A.S., Morimoto, C. and Nadler, L.M. 1991. B-cell surface antigen B7 provides a costimulatory signal that induces T-cells to proliferate and secrete interleukin-2. Proc. Natl. Acad. Sci. USA. 1991. 88: 6575.PubMedCrossRefGoogle Scholar
  15. Golding, B., Golding, H., Preston, S., Hernandez, D., Beining, P.R., Manischewitz, J., Harvath, L., Blackburn, R., Lizzio, E. and Hoffman, T. 1991. Production of a novel antigen by conjugation of HIV-1 to Brucella abortus: studies of immunogenicity, isotype analysis, T-cell dependency and syncytia inhibition. AIDS Res. Hum. Retroviruses, 7: 471.CrossRefGoogle Scholar
  16. Golding, B., Inmann, J., Highet, P., Blackburn, R., Manischewitz, J., Blyveis, N., Angus, R.D. and Golding, H. 1995. Brucella abortus conjugated with a gp 120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type 1 induces neutralizing anti-HIV antibodies, and the V3-B. abortus conjugate is effective even after CD4+ T-cell depletion. J. Virol., 69: 3299.PubMedGoogle Scholar
  17. Goldstein, J., Hoffman, T. Frasch, C., Lizzio, C.L., Beining, P.R., Hochstein, D., Lee, Y.L., Angus, R.D. and Golding, B. 1992. Lipoplysaccharide (LPS) from Brucella abortus is less toxic than lipopoly-saccharide from Escherichia coli, suggesting the possilble use of B. abortus or LPS from B. abortus as a carrier in vaccines. Infect. Immun., 60: 1385.PubMedGoogle Scholar
  18. Guerder, S., Carding, S.R. and Flavell, R.A. 1995. B7 costimulation is necessary for the activation of the lytic function in cytotoxic T lymphocyte precursors. J. Immunol., 155: 5167.PubMedGoogle Scholar
  19. Harding, C.V. and Song, R. 1994. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol., 153: 4925.PubMedGoogle Scholar
  20. Ikonomidis, G., Paterson, Y., Kos, F.J. and Portnoy, D.A. 1994. Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes. J. Exp.Med., 180: 2209.PubMedCrossRefGoogle Scholar
  21. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R.M., Clark, S.C., Chan, S., Loudon, R., Sherman, F., Perussia, B. and Trinchieri, G. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF). A cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med., 170: 827.PubMedCrossRefGoogle Scholar
  22. Koup, R.A., Safrit, J.T., Cao, Y., Andrews, C.A., McLeod, G., Borkowsky, W., Farthing, C. and Ho, D.D. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol., 68: 4650.PubMedGoogle Scholar
  23. Kovacsovics-Bankowski, M., Clark, K., Benacerraf, B. and Rock, K.L. 1993. Efficient major histo-compatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. PNAS, 90: 4942.PubMedCrossRefGoogle Scholar
  24. Lazdins, J. K., Woods-Cook, K., Walker, M. and Alteri, E. 1990. The lipophilic muramyl peptide MTO-PE is a potent inhibitor of HIV replication. AIDS Reserch and Human Retroviruses, 10: 1157.CrossRefGoogle Scholar
  25. Lewis, D. B., Yu, C.C., Meyer, J., English, B.K., Kahn, S.J. and Wilson, C.B. 1991. Cellular and molecular mechanisms for reduced interleukin 4 and interferon-g production by neonatal T cells. J. Clin.Invest., 87: 194.PubMedCrossRefGoogle Scholar
  26. Linsley, P.S., Brady, W., Grossmaire, L., Aruffo, A., Damle, N.K. and Ledbetter, J.A.1991. Binding of the B cell activation antigen B7 to CD28 costimulates T-cell proliferation and intracellular messenger RNA accumulation. J. Exp. Med., 173: 721.PubMedCrossRefGoogle Scholar
  27. Manetti, R., Parronchi, P., Giudizi, M.G., Piccini, M.-P., Maggi, E., Trinchieri, G. and Romagnani, S. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12] induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med., 177: 1199.PubMedCrossRefGoogle Scholar
  28. Manetti, R., Gerosa, F., Giudizi, M.G., Biagiotti, R., Parrochi, P., Piccini, M-P., Sampognaro, S., Maggi, E., Romagnani, S. and Trinchieri, G. 1994. Interleukin 12 induces stable priming for IFN-γ production during differentiation of human T helper (Th) cells and transient IFN-γ production in established Th2 cell clones. J. Exp. Med., 179: 1273.PubMedCrossRefGoogle Scholar
  29. Murphy, E.E., Terres, G., Macatonia, S.E., Hsieh, C.-S., Mattson, J., Lanier, L., Wysocka, M., Trinchieri, G., Murphy, K. and O’Garra, A. 1994. B7 and interleukin 12 cooperate for proliferation and Interferon γ production by mouse T helper clones that are unresponsive to B7 stimulation. J. Exp. Med., 180: 223.PubMedCrossRefGoogle Scholar
  30. O’Garra, A. and Murphy, K. 1994. Role of cytokines in determining T-lymphocyte function. Curr. Opinion in Immunol., 6: 458.CrossRefGoogle Scholar
  31. Perussia, B., Chan, S.H., D’Andrea, A., Tsuji, K., Santoli, D., Pospisil, M., Young, D., Wolf, S.F. and Trinchieri, G. 1992. Natural killer (NK) cells stimulatory factor or IL-12 has differential effects on the proliferation of TcR alpha-beta+, TcR gamma delta+ lymphocytes-T, and NK cells. J. Immunol., 149: 3495.PubMedGoogle Scholar
  32. Pfeifer, J. D., Wick, M.J., Roberts, R.L., Findlay, K., Normark, S.J. and Harding, C.V. 1993. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature, 361: 359.PubMedCrossRefGoogle Scholar
  33. Romani, L., Mencacci, A., Tonnetti, L., Spaccapelo, R., Cenci, E., Wolf, S., Puccetti, P. and Bistoni, F. 1992. Interleukin-12 but not interferon-γ production correlates with induction of T helper type 1 phenotype in murine candidiasis. Eur. J. Immunol., 24: 909.CrossRefGoogle Scholar
  34. Scott, D.E., Agranovich, I., Inman, J., Gober, M. and Golding, B., 1997. Inhibition of primary and recall allergen-specific T helper cell type2-mediated responses by a T helper type 1 stimulus. J.Immunol., 159, in press.Google Scholar
  35. Sedegah, M., Finkelman, F. and Hoffman, S.L. 1994. Interleukin 12 induction of interferon γ-dependentp protection against malaria. Proc. Natl. Acad. Sci. USA, 91: 10700.PubMedCrossRefGoogle Scholar
  36. Shirai, M., Pendleton, C.D., Ahlers, J., Takeshita, T., Newman, N. and Berzofsky, J.A. 1994. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs. J. Immunol., 152: 549.PubMedGoogle Scholar
  37. Snapper, C.M., Peschel, C. and Paul, P. 1988, IFN-gamma stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J. Immunol., 140: 2121.PubMedGoogle Scholar
  38. Stern, A.S., Podlaski, F.J., Hulmes, J.D., Pan, Y.-C., Quinn, P.M., Wolitzky, A.G., Familleti, P.C., Stremlo, D.L., Truitt, T., Chizonite, R. and Gately, M.K. 1990. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA. 87: 6808.PubMedCrossRefGoogle Scholar
  39. Svetic, A., Jian, Y.C., Lu, P., Finkelman, F.D. and Gause, W.C. 1993. Brucella abortus induces a novel cytokine expression pattern characterized by elevated IL-10 and IFN-γ in CD4+ T cells. Int. Immunol., 8: 877.CrossRefGoogle Scholar
  40. Tripp, C.S., Gately, M.K., Hakimi, J., Ling, P. and Unanue, E. 1994. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B17 mice. J. Immunol., 154: 1883.Google Scholar
  41. Van Seventer, G.A., Shimizu, Y., Horgan, K.J. and Shaw, S. 1990. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T-cell receptor mediated activation of resting T-cells. J. Immunol., 144: 4579.PubMedGoogle Scholar
  42. Wolf, S.F., Temple, P.A., Kobayashi, M., Young, D., Dicig, M., Lowe, L., Dzialo, R., Fitz, L., Ferenz, C., Hewick, R.M., Kelleher, K., Herrmann, S.H., Clark, S.C., Azzoni, L., Chan, S.H., Trinchieri, G. and Perussia, B. 1991. Cloning of cDNA from natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T-cells and natural killer cells. J. Immunol., 146: 3074.PubMedGoogle Scholar
  43. Wynn, T.A., Cheever, A.W., Jankovic, D., Poindexter, R.W., Caspar, P., Lewis, F. and Sher, A. 1995. An IL-12 based vaccination method for preventing fibrosis induced by schistosome infection. Nature. 376: 594.PubMedCrossRefGoogle Scholar
  44. Yamauchi, A. and Bloom, E. 1993. Requirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human NK cells. J. Immunol., 151: 1.Google Scholar
  45. Zaitseva, M., Golding, H., Betts, M., Yamauchi, A., Bloom, E.T., Butler, L.E., Steven, L. and Golding, B. 1995. Human peripheral blood CD4+ and CD8+ T cells express Th1-like cytokine mRNA and protein following in vitro stimulation with heat-inactivated Brucella abortus. Infect. Immun., 63: 2720.PubMedGoogle Scholar
  46. Zaitseva, M., Golding, H., Manischewitz, J., Webb, D. and Golding, B. 1996. Brucella abortus as a potential vaccine carrier: Induction of interleukin-12 secretion and enhanced B7.1 and B7.2 and intercellular adhesion molecule 1 surface expression in elutriated human monocytes stimulated by heat-inactivated B. abortus. Infect. Immun., 64: 3109.PubMedGoogle Scholar
  47. Zhang, M., Gately, M., Wang, E., Gong, J., Wolf, S.F., Lu, S., Modlin, R. and Barnes, P. 1994. Interleukin 12 at the site of disease in tuberculosis. J. Clin. Invest., 93: 1733.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • H. Golding
    • 1
  • M. B. Zaitseva
    • 1
  • C. K. Lapham
    • 1
  • B. Golding
    • 2
  1. 1.Laboratory of Retrovirus Research, Division of Viral Products, Center for Biologies Evaluation and ResearchUS Food and Drug AdministrationBethesdaUSA
  2. 2.Laboratory of Plasma Derivatives, Division of Hematology, Center for Biologies Evaluation and ResearchUS Food and Drug AdministrationBethesdaUSA

Personalised recommendations